Resultaten visas 1 - 8 / 8
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Nanosuspension encapsulated chitosan-pectin microbeads as a novel delivery platform for enhancing oral bioavailability

Referentgranskad
Öppen tillgång
DOI
10.1016/j.carbpol.2023.121177
Sampathi, Sunitha; Haribhau, Chormale Jaydeep; Kuchana, Vijaya; Junnuthula, Vijayabhaskarreddy; Dyaw...
Carbohydrate Polymers2023Publicationer information ikon

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension

Referentgranskad
Öppen tillgång
DOI
10.3390/pharmaceutics14091947
Sampathi, Sunitha; Prajapati, Shubham; Junnuthula, Vijayabhaskarreddy; Dyawanapelly, Sathish
Pharmaceutics2022Publicationer information ikon

Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin

Referentgranskad
Öppen tillgång
DOI
10.1016/j.ijpharm.2019.03.064
AH Ibrahim; Emil Rosqvist; Jan-Henrik Smått; HM Ibrahim; HR Ismael; MI Afouna; AM Samy; Jessica Rose...
International Journal of Pharmaceutics2019Publicationer information ikon

Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate

Referentgranskad
DOI
10.1016/j.ijpharm.2012.11.036
Raula, Janne; Rahikkala, Antti; Halkola, Tuomas; Pessi, Jenni; Peltonen, Leena; Hirvonen, Jouni; Jar...
International journal of pharmaceutics2013Publicationer information ikon

Nanoparticle-based oral formulation can surprise you with inferior in vivo absorption in humans

Referentgranskad
Öppen tillgång
DOI
10.1016/j.ejpb.2022.06.009
Singhal, Mayank; Turunen, Elina; Ahtola-Sätilä, Tuula; Aspegren, John; Bratty, J. Raymond; Fuhr, Rai...
European Journal of Pharmaceutics and Biopharmaceutics2022Publicationer information ikon

Therapeutic Potential of Naringenin Nanosuspension:In Vitro and In Vivo Anti-Osteoporotic Studies

Referentgranskad
Öppen tillgång
DOI
10.3390/pharmaceutics14071449
Gera, Sonia; Sampathi, Sunitha; Maddukuri, Sravya; Dodoala, Sujatha; Junnuthula, Vijayabhaskarreddy;...
Pharmaceutics2022Publicationer information ikon

Lipid Architectonics for Superior Oral Bioavailability of Nelfinavir Mesylate:Comparative in vitro and in vivo Assessment

Referentgranskad
DOI
10.1208/s12249-018-1156-3
Belubbi, Tejashree; Shevade, Sukhada; Dhawan, Vivek; Sridhar, Vinay; Majumdar, Anuradha; Nunes, Rute...
AAPS PharmSciTech2018Publicationer information ikon

Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques

Referentgranskad
Öppen tillgång
DOI
10.3390/pharmaceutics10030104
Peltonen, Leena
Pharmaceutics2018

Nanosuspension encapsulated chitosan-pectin microbeads as a novel delivery platform for enhancing oral bioavailability

Referentgranskad
Öppen tillgång
DOI
10.1016/j.carbpol.2023.121177
2023

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension

Referentgranskad
Öppen tillgång
DOI
10.3390/pharmaceutics14091947
2022

Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin

Referentgranskad
Öppen tillgång
DOI
10.1016/j.ijpharm.2019.03.064
2019

Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate

Referentgranskad
DOI
10.1016/j.ijpharm.2012.11.036
2013

Nanoparticle-based oral formulation can surprise you with inferior in vivo absorption in humans

Referentgranskad
Öppen tillgång
DOI
10.1016/j.ejpb.2022.06.009
2022

Therapeutic Potential of Naringenin Nanosuspension:In Vitro and In Vivo Anti-Osteoporotic Studies

Referentgranskad
Öppen tillgång
DOI
10.3390/pharmaceutics14071449
2022

Lipid Architectonics for Superior Oral Bioavailability of Nelfinavir Mesylate:Comparative in vitro and in vivo Assessment

Referentgranskad
DOI
10.1208/s12249-018-1156-3
2018

Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques

Referentgranskad
Öppen tillgång
DOI
10.3390/pharmaceutics10030104
2018